[go: up one dir, main page]

NZ335078A - Composition, for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma, containing loratadine and a decongestant

Info

Publication number
NZ335078A
NZ335078A NZ335078A NZ33507897A NZ335078A NZ 335078 A NZ335078 A NZ 335078A NZ 335078 A NZ335078 A NZ 335078A NZ 33507897 A NZ33507897 A NZ 33507897A NZ 335078 A NZ335078 A NZ 335078A
Authority
NZ
New Zealand
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Application number
NZ335078A
Other languages
English (en)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ335078A publication Critical patent/NZ335078A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ335078A 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant NZ335078A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (fr) 1996-10-31 1997-10-29 Composition destinee au traitement de l'asthme et contenant de la loratadine et un decongestionnant

Publications (1)

Publication Number Publication Date
NZ335078A true NZ335078A (en) 2000-10-27

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335078A NZ335078A (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (fr)
JP (1) JP2000505104A (fr)
KR (1) KR20000052922A (fr)
CN (1) CN1235545A (fr)
AR (1) AR008908A1 (fr)
AU (1) AU731756B2 (fr)
BR (1) BR9712705A (fr)
CA (1) CA2268546A1 (fr)
CO (1) CO4910128A1 (fr)
CZ (1) CZ150999A3 (fr)
HU (1) HUP9904075A3 (fr)
ID (1) ID23431A (fr)
IL (1) IL129662A0 (fr)
NO (1) NO992062D0 (fr)
NZ (1) NZ335078A (fr)
PE (1) PE11399A1 (fr)
PL (1) PL333056A1 (fr)
SK (1) SK54599A3 (fr)
TR (1) TR199901003T2 (fr)
WO (1) WO1998018470A1 (fr)
ZA (1) ZA979731B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
PA8481801A1 (es) * 1998-09-10 2000-09-29 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
CN1161112C (zh) * 1999-02-23 2004-08-11 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
AU4248400A (en) * 2000-04-14 2001-10-30 J Med Pharmaceuticals Inc Single-dose antihistamine/decongestant formulations for treating rhinitis
BR0111018A (pt) * 2000-05-25 2004-02-17 Schering Corp Formulações estáveis lìquidas e sólidas
EP1401444A1 (fr) * 2001-06-20 2004-03-31 Schering Corporation Antihistaminiques pour le traitement de congestion nasale et d'obstruction nasale
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
NZ588134A (en) * 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
TWI411451B (zh) * 2006-06-01 2013-10-11 Msd Consumer Care Inc 用於結腸吸收之脫羥腎上腺素醫藥調配物及組合物
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
PL333056A1 (en) 1999-11-08
JP2000505104A (ja) 2000-04-25
EP0941091A1 (fr) 1999-09-15
NO992062L (no) 1999-04-29
HUP9904075A2 (hu) 2000-05-28
KR20000052922A (ko) 2000-08-25
SK54599A3 (en) 2000-08-14
AR008908A1 (es) 2000-02-23
WO1998018470A1 (fr) 1998-05-07
IL129662A0 (en) 2000-02-29
BR9712705A (pt) 1999-10-26
ZA979731B (en) 1998-04-29
AU4995397A (en) 1998-05-22
AU731756B2 (en) 2001-04-05
CO4910128A1 (es) 2000-04-24
HUP9904075A3 (en) 2002-02-28
NO992062D0 (no) 1999-04-29
CZ150999A3 (cs) 1999-10-13
ID23431A (id) 2000-04-20
CA2268546A1 (fr) 1998-05-07
CN1235545A (zh) 1999-11-17
PE11399A1 (es) 1999-02-09
TR199901003T2 (xx) 1999-07-21

Similar Documents

Publication Publication Date Title
NZ335078A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
EP0950665A4 (fr) Proteines modifiees physiologiquement actives et compositions medicamenteuses les contenant
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HUP9901874A3 (en) Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof
CA2195093A1 (fr) Utilisation du droloxifene pour le traitement des affections prostatiques, de l'endometriose et de l'obesite
GR1003350B (el) Νεες ενωσεις
CA2271944A1 (fr) Formulation destinee a un apport par assistance electrique de lidocaine et d'epinephrine
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
CY2482B1 (en) Paroxetine in treatment of depression.
ZA973843B (en) Treatment of asthma with TNFR-lg.
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
BG104914A (en) Paroxetine maleate
MXPA01005600A (es) Peptidos pequenos y metodos para tratamiento de asma e inflamacion.
GB9420616D0 (en) Method, compositions and use
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
AU5554598A (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
MD980129A (en) Antiherpetic remedy
HK1018941A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
EP0824101B1 (fr) Dendrimère carbosilanique contenant des liaisons Si-O-métal, procédé pour leur préparation et leur utilisation
AU5257198A (en) Compositions and methods for treating type ii diabetes involving hnf-4
HUP0104262A3 (en) Pharmaceutical composition containing 2,4-dioxothiazolidine-derivative and process for its use
AU2973997A (en) Use of substituted azaspirane in the treatment of asthma
AU3423397A (en) Therapeutic methods and compositions for use therein
AU1237495A (en) Organopathy preventing, curing or ameliorating agent